Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CHEUNG, P. K.
Right arrow Articles by BAKKER, W. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CHEUNG, P. K.
Right arrow Articles by BAKKER, W. W.
J Am Soc Nephrol 10:1700-1708, 1999
© 1999 American Society of Nephrology


REGULAR ARTICLES

Is 100KF an Isoform of Hemopexin? Immunochemical Characterization of the Vasoactive Plasma Factor 100KF

PO KAM CHEUNG*, BEN STULP*, STEPHAN IMMENSCHUH{dagger}, THEO BORGHUIS*, JULIUS F. W. BALLER* and WINSTON W. BAKKER*

* Department of Pathology, University of Groningen, The Netherlands
{dagger} Department of Internal Medicine, Georg-August-University, Göttingen, Germany.

Correspondence to Dr. Winston W. Bakker, Department of Pathology, University of Groningen, P. O. Box 30.001, 9700 RB Groningen, The Netherlands. Phone: +31 50 3619527; Fax: +31 50 3632510; E-mail: w.w.bakker{at}path.azg.nl

Abstract

Abstract. The human vasoactive plasma factor 100KF has been proposed to play a role in minimal change disease in relapse. Since preliminary data suggested similarity between 100KF and the human plasma glycoprotein hemopexin (Hx), this study was conducted to compare 100KF with purified Hx for sequence homology, immunostaining properties in Western and dot-blot assays, ability to affect glomerular ecto-ATPase and glomerular polyanions in vitro, as well as their glomerular permeability increasing effect following alternate perfusion into the rat kidney ex vivo. 100KF was purified from normal pooled plasma according to standard chromatographic techniques, and from the same batch Hx was prepared using affinity chromatography. A second batch of Hx was prepared directly from human serum according to a standard protocol. (For comparison, additional Hx samples obtained from other centers were also included in the study.) The results show: (1) 100% homology of 100KF with plasma Hx after internal sequence analysis; (2) positive staining of the eluate with both monoclonal and polyclonal anti-Hx IgG as well as anti-100KF IgG in dot-blot assays, and similar bands on Western blotting using the same antibodies; (3) affection of glomerular polyanions and glomerular ecto-ATPase after incubation of kidney tissue with either 100KF or Hx (1.5 respectively 1.0 mg/ml; 1.0 h, 37°C), as detected by computerized histochemical quantification; and (4) significant enhancement of urinary protein leakage after Hx perfusion followed by diluted rat serum into the rat kidney ex vivo (Hx: 210.65 ± 49.79 µg protein leakage per min versus heat-inactivated Hx control: 112.2 ± 49.18 µg per min [both n = 6]). From these data and from the observation that both Hx and 100KF activity can be inhibited by serine protease inhibitors but not by broad spectrum collagenase inhibitors, it is concluded that Hx may be closely related or identical to the active moiety of 100KF.




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
R. Lennon, A. Singh, G. I. Welsh, R. J. Coward, S. Satchell, L. Ni, P. W. Mathieson, W. W. Bakker, and M. A. Saleem
Hemopexin Induces Nephrin-Dependent Reorganization of the Actin Cytoskeleton in Podocytes
J. Am. Soc. Nephrol., November 1, 2008; 19(11): 2140 - 2149.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
G. Boner, A. J. Cox, D. J. Kelly, A. Tobar, J. Bernheim, R. G. Langham, M. E. Cooper, and R. E. Gilbert
Does vascular endothelial growth factor (VEGF) play a role in the pathogenesis of minimal change disease?
Nephrol. Dial. Transplant., November 1, 2003; 18(11): 2293 - 2299.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP